Cornwall holiday lettings 'upstart' aims for £10m turnover

'We saw the niche and we grasped it'

DHR Sep 2024 290.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

4.3000

-0.4000

(-8.51%)

As of 01:25PM EDT. Market open.

Loading interactive chart…

GuruFocus.com
Insider Sale: President & CEO Rainer Blair Sells 9,005 Shares of Danaher Corp (DHR)
On May 16, 2024, Rainer Blair, President & CEO of Danaher Corp (NYSE:DHR), executed a sale of 9,005 shares of the company.
Zacks
Danaher (DHR) Rides on Business Strength Amid Headwinds
Danaher (DHR) gains from strength in academic and applied markets, Abcam buyout and pro-investor policies. However, softness in its Biotechnology unit is concerning.
The Telegraph
Questor: This biotech giant is backed by the world’s best fund managers
Remember Abcam? The Cambridge-based biotech was a darling of the Aim market until it decided in late-2022 to abandon London in favour of a listing on the US exchange Nasdaq.